XML 55 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation (Tables)
12 Months Ended
Apr. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity [Table Text Block]
The following table presents information about SSARs outstanding as of April 30, 2019, and for the year then ended.
 
Number of
SSARs
(in thousands)
 
Weighted-
Average
Exercise Price
per SSAR
 
Weighted-
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic Value
Outstanding at April 30, 2018
7,215

 
$
29.67

 
 
 
 
Granted
605

 
54.00

 
 
 
 
Exercised
(903
)
 
17.13

 
 
 
 
Forfeited or expired
(65
)
 
52.49

 
 
 
 
Outstanding at April 30, 2019
6,852

 
$
33.25

 
4.9
 
$
138

Exercisable at April 30, 2019
4,381

 
$
28.10

 
3.6
 
$
110

Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]
The weighted-average grant-date fair values and related valuation assumptions for the SSARS granted during each of the last three years were as follows:
 
2017
 
2018
 
2019
Grant-date fair value
$
5.73

 
$
6.79

 
$
11.06

Valuation assumptions:
 
 
 
 
 
Expected term (years)
7.00

 
7.00

 
7.00

Risk-free interest rate
1.4
%
 
2.2
%
 
2.9
%
Expected volatility
16.3
%
 
15.6
%
 
17.1
%
Expected dividend yield
1.6
%
 
1.5
%
 
1.4
%
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The following table presents information about RSUs outstanding as of April 30, 2019, and for the year then ended.
 
Number of
RSUs
(in thousands)
 
Weighted-
Average
Fair Value at
Grant Date
Outstanding at April 30, 2018
418

 
$
42.90

Granted
98

 
$
55.29

Converted to common shares
(123
)
 
$
45.44

Forfeited
(11
)
 
$
55.15

Outstanding at April 30, 2019
382

 
$
44.91

Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions [Table Text Block]
The weighted average grant-date fair values and related valuation assumptions for these awards granted during each of the last three years were as follows:
 
2017
 
2018
 
2019
Grant-date fair value
$
38.07

 
$
46.93

 
$
55.29

Valuation assumptions:
 
 
 
 
 
Risk-free interest rate
0.8
%
 
1.5
%
 
2.7
%
Expected volatility
17.8
%
 
18.9
%
 
20.8
%
Expected dividend yield
1.3
%
 
1.4
%
 
1.2
%
Remaining performance period (years) as of grant date
2.8

 
2.8

 
2.8

Grant Date Fair Values of DSUs [Table Text Block]
The weighted average grant-date fair values for these awards granted during each of the last three years were as follows:
 
2017
 
2018
 
2019
Grant-date fair value
$
42.06

 
$
41.81

 
$
54.20

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The pre-tax stock-based compensation expense and related deferred income tax benefits recognized during the last three fiscal years were as follows:
 
2017
 
2018
 
2019
Pre-tax compensation expense
$
14

 
$
19

 
$
14

Deferred tax benefit
5

 
6

 
2

Stock-Based Awards, Other Information [Table Text Block]
Further information related to our stock-based awards for the last three years is as follows:
 
2017
 
2018
 
2019
Intrinsic value of SSARs exercised
$
28

 
$
73

 
$
31

Fair value of shares vested1
8

 
6

 
20

Excess tax benefit from exercise / vesting of awards
9

 
18

 
7